Prognostic Value of Exercise-Induced Ventricular Arrhythmia in Chagas' Heart Disease

Objective:  To determine the prevalence and the prognostic value of exercise‐induced ventricular arrhythmia (EIVA) in chronic Chagas’ heart disease. Study Design and Setting:  An open prospective cohort of 130 clinically stable patients at a University Hospital outpatient unit in Rio de Janeiro, Bra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pacing and clinical electrophysiology 2011-11, Vol.34 (11), p.1492-1497
Hauptverfasser: PEDROSA, ROBERTO COURY, SALLES, JOSÉ HUGO GAMEIRO, MAGNANINI, MONICA M. F., BEZERRA, DANIEL C., BLOCH, KATIA VERGETTI
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective:  To determine the prevalence and the prognostic value of exercise‐induced ventricular arrhythmia (EIVA) in chronic Chagas’ heart disease. Study Design and Setting:  An open prospective cohort of 130 clinically stable patients at a University Hospital outpatient unit in Rio de Janeiro, Brazil, was followed up at scheduled clinical visits from 1990 through 2007. The endpoint was total cardiovascular mortality. Survival curves (Kaplan‐Meier) and a multivariate Cox proportional hazard model were adjusted to determine the association between EIVA and mortality. Results:  The median duration of follow‐up was 9.9 years (range, 132 days to 17 years). EIVA prevalence was 43.1% (95% CI: 34.5–51.7). Thirty‐three cardiovascular deaths (25.4%) occurred. The hazard ratio of EIVA for cardiovascular death, after adjustment for age, was 1.84 (P = 0.09). An interaction was found between EIVA and cardiomegaly on x‐ray. In the group with cardiomegaly, the hazard of dying was four times greater in the presence of EIVA (P for interaction = 0.05). Conclusion:  In clinically stable chagasic subjects with cardiomegaly, EIVA is a clinically significant marker of total cardiovascular mortality and may be a useful risk stratification tool in this population. (PACE 2011; 34:1492–1497)
ISSN:0147-8389
1540-8159
DOI:10.1111/j.1540-8159.2011.03171.x